Elutia Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ELUT Nasdaq 2836 elutia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Elutia Inc.

Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - Jan 12th, 2026 6:00 am
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery - Jan 9th, 2026 6:00 am
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know - Dec 31st, 2025 10:00 am
How The BioEnvelope Sale Is Changing Elutia’s Story and Shaping Its Future Valuation - Dec 2nd, 2025 9:08 am
M&A Strategy Strengthens Boston Scientific's Growth Prospects - Dec 2nd, 2025 5:56 am
Why Analysts See a Shifting Story for Elutia After the BioEnvelope Sale - Nov 17th, 2025 5:14 pm
Elutia Inc (ELUT) Q3 2025 Earnings Call Highlights: Strategic Growth and Financial Resilience - Nov 6th, 2025 10:11 pm
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development - Nov 6th, 2025 2:05 pm
How Analyst Views Are Shifting as Elutia Refocuses After Its BioEnvelope Sale - Nov 2nd, 2025 12:11 am
Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - Oct 23rd, 2025 2:05 pm
Tracking the Evolving Story for Elutia After the BioEnvelope Sale - Oct 17th, 2025 7:15 pm
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21 - Oct 14th, 2025 2:05 pm
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors - Oct 10th, 2025 6:00 am
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Oct 1st, 2025 6:41 am
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation - Sep 16th, 2025 6:00 am
Boston Scientific (BSX): Examining Valuation Following Leadership Change and FARAPULSE FDA Rollout - Sep 11th, 2025 6:02 am
Elutia to divest bioenvelopes business to Boston Scientific for $88m - Sep 11th, 2025 3:18 am
Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround - Sep 10th, 2025 7:35 am
Boston Scientific inks $88M Elutia deal to challenge Medtronic - Sep 10th, 2025 4:20 am
Sector Update: Health Care Stocks Advance Late Afternoon - Sep 9th, 2025 1:52 pm